April 2009

Assessing India’s Innovation Climate

April 23, 2009

In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products must “differ significantly in properties with regard to efficacy.” This requirement for a significant improvement in efficacy only applies to drugs — not to other patentable inventions like pens, car engines, etc., and is of [...]

Read the full article →

An Overview of the Biopharmaceutical Landscape Ahead

April 16, 2009

John Avellanet, a frequent contributor to this blog, is giving a talk for my biotechnology management class at the NIH next week. He’s posted his slides and some background readings on his web site at http://www.ceruleanllc.com/NIH/. These materials will only be available until April 25th, so hurry on over and read them.

Read the full article →

Measuring global biotechnology innovation

April 9, 2009

The Scientific American WorldView project, where I’ve been serving as lead editorial consultant, is ramping up for its May 20th launch at BIO 2009. One of the objectives for the project was to put marketing-speak aside and objectively measure biotechnology innovation progress around the world. Going beyond gross regional measures, we compare individual countries to [...]

Read the full article →

Drug Patent Expirations in April 2009

April 1, 2009

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in April 2009 *Drugs may be covered by multiple patents

Read the full article →